Current Report Filing (8-k)
December 21 2017 - 10:24AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 19, 2017
Imaging3,
Inc.
(Exact
name of registrant as specified in its charter)
|
California
|
|
000-50099
|
|
95-4451059
|
|
(State
or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S.
Employer
|
|
of
Incorporation)
|
|
File
Number)
|
|
Identification
No.)
|
3022
North Hollywood Way. Burbank, CA 91505
(Address
of Principal Executive Offices) (Zip Code)
818
260 0930
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item
5.02 Appointment of Certain Officers .
On
December 19, 2017 the Company appointed John B. Hollister to serve as the Company’s Chief Executive Officer and Chairman
of the Board of Directors of the Company. Mr. Hollister shall serve at will and the contract may be terminated by the Company
or Mr. Hollister without notice. Until his appointment, Mr. Hollister served as CEO of NuLife Sciences, Inc. since October 17,
2016. From July 2014 to August 24, 2015 Mr. Hollister served as CEO of NEMUS Bioscience, Inc. From June 2011 to July 2013 Mr.
Hollister served as Senior Vice President of Tethys Bioscience, Inc.
Mr.
Hollister’s agreement calls for him to be paid an initial Salary of $ 17,500.00 per month rising to $26,500.00 per month
if he achieves certain goals, and an annual bonus of up to $200,000.00 and certain Special Bonuses at the discretion of the Company’s
board of directors. A copy of the Agreement between the Company and Mr. Hollister is attached hereto as Exhibit 1.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
|
Imaging3,
Inc.
|
|
|
|
|
|
|
By:
|
/s/
Dane Medley
|
|
|
Name:
|
Dane
Medley
|
|
|
Title:
|
President
and Principal Executive Officer
|
|
|
|
|
|
Date:
December 21, 2017
|
|
|
Exhibit 1.
Consulting and Employment Agreement